Eric P. Palmer - 09 Feb 2024 Form 4 Insider Report for Cigna Group (CI)

Signature
Matthew Arnold, attorney-in-fact
Issuer symbol
CI
Transactions as of
09 Feb 2024
Transactions value $
-$340,956
Form type
4
Filing time
13 Feb 2024, 17:28:07 UTC
Previous filing
06 Feb 2024
Next filing
15 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Sale -$341K -1.02K -2.18% $335.26 45.6K 09 Feb 2024 Direct F1, F2
holding CI Common Stock, $.01 Par Value 245 09 Feb 2024 By 401(k) F3
holding CI Common Stock, $.01 Par Value 41.1 09 Feb 2024 By Spouse's 401(k) F3
holding CI Common Stock, $.01 Par Value 1.13K 09 Feb 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 7, 2023. In compliance with SEC guidance, the reporting person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2 Represents the weighted average price of the shares sold. The prices actually received ranged from $335.211 to $335.29 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
F3 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.

Remarks:

EVP, Enterprise Strategy and President & CEO, Evernorth Health Services